Nivolumab in Children and Young Adults with Relapsed or Refractory Solid Tumours or Lymphoma (ADVL1412): a Multicentre, Open-Label, Single-Arm, Phase 1–2 Trial
The Lancet Oncology（2020）
Key words
PD-1 and PD-L1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined